US Patent 11981684 Macrocyclic compounds and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Turning Point Therapeutics

Current Assignee

Turning Point Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119816840

Patent Inventor Names

Jeffrey Whitten0

Jane Ung0

Zhongdong Huang0

Evan W. Rogers0

Han Zhang0

Wei Deng0

Dayong Zhai0

Jingrong Jean Cui0

...

Date of Patent

May 14, 2024

Patent Application Number

176769420

Date Filed

February 22, 2022

Patent Citations

‌

US Patent 10246466 Diaryl macrocycles as modulators of protein kinases

‌

US Patent 10294242 Diaryl macrocycle polymorph

‌

US Patent 10316044 Chiral diaryl macrocycles as modulators of protein kinases

‌

US Patent 10689400 Macrocycle kinase inhibitors

‌

US Patent 11286264 Macrocyclic compounds and uses thereof

‌

US Patent 11155563 Macrocyclic compounds and uses thereof

‌

US Patent 8497270 Macrocyclic integrase inhibitors

‌

US Patent 8680111 Macrocyclic derivatives for the treatment of diseases

...

Patent Primary Examiner

CPC Code

Patent abstract

The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11981684 Macrocyclic compounds and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11981684 Macrocyclic compounds and uses thereof